Publications

Press

Crowley, Kavanagh, and Holmes on FDA’s Approval of Lenacapavir for HIV Prevention

This afternoon, the FDA approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued…

June 18, 2025

Publication

Zero-Draft Framework for Tracking Implementation of the Pandemic Agreement

The Pandemic Agreement directs the Conference of Parties (COP) to create a mechanism to facilitate and strengthen implementation, including by monitoring key commitments and progress. In support of…

May 21, 2025

Press

Dr. Matthew M. Kavanagh on First-ever Pandemic Agreement

The O’Neill Institute issued the following statement from Dr. Matthew M. Kavanagh, director of the Center for Global Health Policy and Politics, in response to Member States of the WHO formally…

May 20, 2025

Expert Column

Pricing of Monoclonal Antibodies: The Need for Greater Transparency to Promote Global Access 

Aditi Mahajan, Jacqueline DeverFormer Research Assistants, Center for Global Health Policy & Politics Introduction Monoclonal antibodies (mAbs), first generated in 1975, have been widely…

August 22, 2025

Expert Column

Global Health in Crisis: An Analysis of U.S. Spending on Life-Saving Health Programs

Vaccination for mpox kicked off in the Democratic Republic of the Congo (DRC) on October 2024, almost two years after the outbreak was declared in December 2022 and five years after the…

April 3, 2025

Expert Column

The Neglected Pandemic: Efforts (and Lack Thereof) to Develop Vaccines Against Cholera

Sanjana Mukherjee Fellow As multilateral negotiations on pandemic prevention, preparedness, and response continue in Geneva, one pandemic continues to linger globally, largely unnoticed by the…

April 16, 2024